Back to Market Feed

PROGLYCEM 50 MG/ML ORAL SUSP

$16.9362per ML

Strength

50 mg/mL

Manufacturer

Teva Pharmaceuticals USA Inc.

NDC

00575620030

Classification

Brand

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

Approval Type

New Drug (NDA)

FDA Application

On Market Since

9/30/1990

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+10.7%

1Y

+9.8%

3Y

+53.6%

5Y

+53.6%

All

+143.0%

Generic Alternatives

Save up to 61%

1 alternative • Same active ingredient

DIAZOXIDE 50 MG/ML ORAL SUSP

13517010030•e5 Pharma, LLC

Related Drugs

Same classification

No related drugs found.